FDA Approves Promising Alzheimer’s Treatment

Leading Florida Neurologists Available to Speak about Biogen Aducanumab Treatment Alzheimer’s patients and their families, as well as the medical community, are celebrating today’s decision by the FDA to approve Biogen’s Aducanumab, a promising infusion treatment for Alzheimer’s patients. Dr. Jeffrey Gelblum, MD, a board-certified neurologist with First Choice Neurology, the nation’s largest neurology practice, …

FDA Approves Promising Alzheimer’s Treatment Read More »